Stryker sell the Hi-Rise unit for $410,000 in the US Market and CVB sells to Stryker for $360,000 in which CVB makes 50% Gross Profit - with recurring revenue of $25000-$30'000 in service charges.This technology is first to market opportunity with a targeted 10 Billion US Market and 2.7 Billion - (SAAS) CVB AI Platform .
With the implications of the stream line created by in-house bone density tests ( one patient visit) this is compelling IMHO from my medical background with Doctors re- enbursments $240 Cat Scan - $140 Bone Density Test.
Harvard,Penn,UCLA,HSS are hospitals already using the Hi-Rise with Stryker moving on the group surgeon medical centre which will follow the the US Hospitals success.
The FDA approval this week for the full - body scan is very exciting and it's potential IMHO
Stryker sell the Hi-Rise unit for $410,000 in the US Market and...
Add CVB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $39.70M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 12.5¢ | $10.22K | 78.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8000 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 483 | 1 |
View Market Depth
| Last trade - 15.55pm 09/10/2024 (20 minute delay) ? |
| CVB (ASX) Chart |